<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02799641</url>
  </required_header>
  <id_info>
    <org_study_id>15-062</org_study_id>
    <nct_id>NCT02799641</nct_id>
  </id_info>
  <brief_title>Effect of Multimodal Analgesia on Pain With Insertion of Levonorgestrel-releasing IUD</brief_title>
  <official_title>Double-blind, Randomized, Placebo-controlled Study on the Effect of Multimodal Analgesia on Pain With Insertion of Levonorgestrel-releasing Intrauterine System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriHealth Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TriHealth Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Does the addition of cervical lidocaine injections and valium to the current practice result
      in decreased reported pain with tenaculum placement, IUD insertion, and post procedural
      discomfort? The current practice is ibuprofen alone or no medication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Long acting reversible contraception, including intrauterine devices (IUDs), provide birth
      control for an extended period of time. IUDs are the most effective type of reversible birth
      control for women who do not wish to become pregnant over the next couple years, have the
      lowest failure rate (Winner, 2012), and in 2007, were used by more than 180 million women
      worldwide (Darney, 2010). Despite the high efficacy and low rates of side effects, women may
      decline placement of an IUD due to fear of pain associated with placement. IUDs may act as a
      barrier to women selecting this method of contraception. Currently there is no consensus in
      the literature as to the most effective way to address analgesia surrounding IUD insertion.

      In order to eliminate barriers to selecting the IUD for contraception, improve the experience
      of women undergoing placement, and standardize local practices, investigators want to
      investigate analgesic options affecting patients' perception of pain during the various steps
      of IUD insertion.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS (Visual Analog Score) pain score</measure>
    <time_frame>At IUD insertion</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control arm receives ibuprofen, placebo pill, and placebo injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment arm receives ibuprofen, diazepam pill, and lidocaine injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diazepam</intervention_name>
    <description>5 mg Diazepam</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Valium</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>2 ml of 2% lidocaine</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo pill</intervention_name>
    <description>Placebo pill</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo injection</intervention_name>
    <description>Placebo injection</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years of age,

          -  Desires to undergo placement of a levonorgestrel containing intrauterine device

        Exclusion Criteria:

          -  Device manufacturer contraindications such as signs of genital infection, positive
             urine pregnancy test, abnormal vaginal bleeding, abnormal sized uterus that sounds
             &lt;6cm or &gt;10cm, and all other contraindications to placement of a levonorgestrel
             containing IUD.

          -  Patients with a history of drug abuse.

          -  History of a prior IUD

          -  Current use of medications for anxiety

          -  Also, a diagnosis of chronic pain.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catrina Crisp, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>TriHealth Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ganga Devaiah, MS</last_name>
    <phone>513-862-2341</phone>
    <email>ganga_devaiah@trihealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pam Plummer, MSN, RN</last_name>
    <phone>513-862-6918</phone>
    <email>pam_plummer@trihealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bethesda North Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Romero L, Pazol K, Warner L, Gavin L, Moskosky S, Besera G, Loyola Briceno AC, Jatlaoui T, Barfield W; Centers for Disease Control and Prevention (CDC). Vital signs: trends in use of long-acting reversible contraception among teens aged 15-19 years seeking contraceptive servicesâ€”United States, 2005-2013. MMWR Morb Mortal Wkly Rep. 2015 Apr 10;64(13):363-9.</citation>
    <PMID>25856258</PMID>
  </reference>
  <reference>
    <citation>Li R, Ruckle HC, Creech JD, Culpepper DJ, Lightfoot MA, Alsyouf M, Nicolay L, Jellison F, Baldwin DD. A prospective, randomized, controlled trial assessing diazepam to reduce perception and recall of pain during transrectal ultrasonography-guided biopsy of the prostate. J Endourol. 2014 Jul;28(7):881-6. doi: 10.1089/end.2014.0043. Epub 2014 May 5.</citation>
    <PMID>24641687</PMID>
  </reference>
  <reference>
    <citation>Pergialiotis V, Vlachos DG, Protopappas A, Vlachos GD. Analgesic options for placement of an intrauterine contraceptive: a meta-analysis. Eur J Contracept Reprod Health Care. 2014 Jun;19(3):149-60. doi: 10.3109/13625187.2014.903238. Epub 2014 May 14. Review.</citation>
    <PMID>24828514</PMID>
  </reference>
  <reference>
    <citation>Ekelund M, Melander M, Gemzell-Danielsson K. Intrauterine contraception: attitudes, practice, and knowledge among Swedish health care providers. Contraception. 2014 May;89(5):407-12. doi: 10.1016/j.contraception.2013.12.014. Epub 2014 Jan 7.</citation>
    <PMID>24485096</PMID>
  </reference>
  <reference>
    <citation>Goldthwaite LM, Baldwin MK, Page J, Micks EA, Nichols MD, Edelman AB, Bednarek PH. Comparison of interventions for pain control with tenaculum placement: a randomized clinical trial. Contraception. 2014 Mar;89(3):229-33. doi: 10.1016/j.contraception.2013.11.018. Epub 2013 Dec 10.</citation>
    <PMID>24405796</PMID>
  </reference>
  <reference>
    <citation>Facco E, Stellini E, Bacci C, Manani G, Pavan C, Cavallin F, Zanette G. Validation of visual analogue scale for anxiety (VAS-A) in preanesthesia evaluation. Minerva Anestesiol. 2013 Dec;79(12):1389-95. Epub 2013 Jul 9.</citation>
    <PMID>23860442</PMID>
  </reference>
  <reference>
    <citation>Scavuzzi A, Souza AS, Costa AA, Amorim MM. Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Hum Reprod. 2013 Aug;28(8):2118-25. doi: 10.1093/humrep/det240. Epub 2013 Jun 5.</citation>
    <PMID>23739219</PMID>
  </reference>
  <reference>
    <citation>Ibrahim ZM, Sayed Ahmed WA. Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. Eur J Contracept Reprod Health Care. 2013 Aug;18(4):300-8. doi: 10.3109/13625187.2013.800855. Epub 2013 Jun 10.</citation>
    <PMID>23751152</PMID>
  </reference>
  <reference>
    <citation>Waddington A, Reid R. More harm than good: the lack of evidence for administering misoprostol prior to IUD insertion. J Obstet Gynaecol Can. 2012 Dec;34(12):1177-1179. doi: 10.1016/S1701-2163(16)35465-2. Review.</citation>
    <PMID>23231800</PMID>
  </reference>
  <reference>
    <citation>Rossi V, Pourtois G. Transient state-dependent fluctuations in anxiety measured using STAI, POMS, PANAS or VAS: a comparative review. Anxiety Stress Coping. 2012 Nov;25(6):603-45. doi: 10.1080/10615806.2011.582948. Epub 2011 Aug 10. Review.</citation>
    <PMID>21827372</PMID>
  </reference>
  <reference>
    <citation>Polyzos NP, Zavos A, Valachis A, Dragamestianos C, Blockeel C, Stoop D, Papanikolaou EG, Tournaye H, Devroey P, Messinis IE. Misoprostol prior to hysteroscopy in premenopausal and post-menopausal women. A systematic review and meta-analysis. Hum Reprod Update. 2012 Jul;18(4):393-404. doi: 10.1093/humupd/dms014. Epub 2012 Apr 27. Review.</citation>
    <PMID>22544173</PMID>
  </reference>
  <reference>
    <citation>Chor J, Bregand-White J, Golobof A, Harwood B, Cowett A. Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: a randomized controlled trial. Contraception. 2012 Jun;85(6):558-62. doi: 10.1016/j.contraception.2011.10.015. Epub 2011 Dec 15.</citation>
    <PMID>22176793</PMID>
  </reference>
  <reference>
    <citation>Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012 May 24;366(21):1998-2007. doi: 10.1056/NEJMoa1110855.</citation>
    <PMID>22621627</PMID>
  </reference>
  <reference>
    <citation>Edelman AB, Schaefer E, Olson A, Van Houten L, Bednarek P, Leclair C, Jensen JT. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception. 2011 Sep;84(3):234-9. doi: 10.1016/j.contraception.2011.01.016. Epub 2011 Mar 3.</citation>
    <PMID>21843686</PMID>
  </reference>
  <reference>
    <citation>Trussell J. Contraceptive failure in the United States. Contraception. 2011 May;83(5):397-404. doi: 10.1016/j.contraception.2011.01.021. Epub 2011 Mar 12. Review.</citation>
    <PMID>21477680</PMID>
  </reference>
  <reference>
    <citation>Dijkhuizen K, Dekkers OM, Holleboom CA, de Groot CJ, Hellebrekers BW, van Roosmalen GJ, Janssen CA, Helmerhorst FM. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod. 2011 Feb;26(2):323-9. doi: 10.1093/humrep/deq348. Epub 2010 Dec 15.</citation>
    <PMID>21159683</PMID>
  </reference>
  <reference>
    <citation>Heikinheimo O, Inki P, Kunz M, Parmhed S, Anttila AM, Olsson SE, Hurskainen R, Gemzell-Danielsson K. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception. 2010 Jun;81(6):481-6. doi: 10.1016/j.contraception.2010.01.020. Epub 2010 Mar 1.</citation>
    <PMID>20472114</PMID>
  </reference>
  <reference>
    <citation>Talamo G, Liao J, Bayerl MG, Claxton DF, Zangari M. Oral administration of analgesia and anxiolysis for pain associated with bone marrow biopsy. Support Care Cancer. 2010 Mar;18(3):301-5. doi: 10.1007/s00520-009-0652-0. Epub 2009 May 21.</citation>
    <PMID>19455356</PMID>
  </reference>
  <reference>
    <citation>Park SH, Bang SM, Nam E, Cho EK, Shin DB, Lee JH, Ahn JY. A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy. Pain Med. 2008 Mar;9(2):249-52. doi: 10.1111/j.1526-4637.2006.00284.x.</citation>
    <PMID>18298709</PMID>
  </reference>
  <reference>
    <citation>SÃ¤Ã¤v I, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007 Oct;22(10):2647-52. Epub 2007 Jul 25.</citation>
    <PMID>17652452</PMID>
  </reference>
  <reference>
    <citation>Davey HM, Barratt AL, Butow PN, Deeks JJ. A one-item question with a Likert or Visual Analog Scale adequately measured current anxiety. J Clin Epidemiol. 2007 Apr;60(4):356-60. Epub 2006 Dec 27.</citation>
    <PMID>17346609</PMID>
  </reference>
  <reference>
    <citation>Preutthipan S, Herabutya Y. A randomized comparison of vaginal misoprostol and dinoprostone for cervical priming in nulliparous women before operative hysteroscopy. Fertil Steril. 2006 Oct;86(4):990-4. Epub 2006 Sep 1.</citation>
    <PMID>16949590</PMID>
  </reference>
  <reference>
    <citation>Murty J. Use and effectiveness of oral analgesia when fitting an intrauterine device. J Fam Plann Reprod Health Care. 2003 Jul;29(3):150-1.</citation>
    <PMID>12885310</PMID>
  </reference>
  <reference>
    <citation>Wiebe E, Podhradsky L, Dijak V. The effect of lorazepam on pain and anxiety in abortion. Contraception. 2003 Mar;67(3):219-21.</citation>
    <PMID>12618257</PMID>
  </reference>
  <reference>
    <citation>Kuganeswaran E, Clarkston WK, Cuddy PG, Quiason SG, Pandya PK, Dierenfeldt WT, Jonnalagadda SS, Smith OJ, Chen ST. A double-blind placebo controlled trial of oral midazolam as premedication before flexible sigmoidoscopy. Am J Gastroenterol. 1999 Nov;94(11):3215-9.</citation>
    <PMID>10566717</PMID>
  </reference>
  <reference>
    <citation>Hornblow AR, Kidson MA. The visual analogue scale for anxiety: a validation study. Aust N Z J Psychiatry. 1976 Dec;10(4):339-41.</citation>
    <PMID>1071419</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2015</study_first_submitted>
  <study_first_submitted_qc>June 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2016</study_first_posted>
  <last_update_submitted>October 10, 2017</last_update_submitted>
  <last_update_submitted_qc>October 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contraception</keyword>
  <keyword>IUD</keyword>
  <keyword>levonorgestrel releasing intrauterine device</keyword>
  <keyword>lidocaine</keyword>
  <keyword>valium</keyword>
  <keyword>diazepam</keyword>
  <keyword>pain</keyword>
  <keyword>VAS</keyword>
  <keyword>visual analog scale</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Diazepam</mesh_term>
    <mesh_term>Levonorgestrel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

